三九医药2005年第一季度报告（节录）_医药资讯

财务资料1、主要会计数据及财务指标单位：人民币元本报告期末上年度期末本报告期比上年度末增减（％）总资产7,063,788,138.977,177,607,192.83-1.59股东权益（不含少数股东权益）2,164,065,932.322,113,879,359.622.37每股净资产2.212.162.31调整后的每股净资产0.600.559.09报告期年初至报告期期末本报告期比上年同期增减（％）经营活动产生的现金流量净额21,222,381.6421,222,381.64-51.54每股收益0.050.05192.40净资产收益率2.32%2.32%1.75扣除非经常性损益后的净资产收益率1.41%1.41%1.14非经常性损益项目金额处置固定资产、在建工程、无形资产、其他长期资产产生的损益；0对非金融企业收取的资金占用费；14,440,577.07其他各项营业外收入8,151,849.51扣除资产减值后其他各项营业外支出-882,934.22所得税0少数股东损益2,088,056.98非经常性损益合计21,709,492.362、利润及利润分配表单位：人民币元项目合并数母公司2005年1-3月2004年1-3月2005年1-3月2004年1-3月一、主营业务收入698,840,557.82436,004,991.78173,063,169.00111,782,150.65减：主营业务成本405,932,895.22237,196,645.9567,851,868.6647,128,449.63主营业务税金及附加2,460,267.491,228,655.18952,217.99464,690.87二、主营业务利润290,447,395.11197,579,690.65104,259,082.3564,189,010.15加：其他业务利润5,650,548.752,004,368.640.000.00减：营业费用127,257,485.3269,807,168.9013,851,005.871,165,868.50管理费用66,924,919.5367,103,164.6515,061,650.1514,306,927.75财务费用35,478,186.3635,825,059.0729,829,305.5530,110,314.36三、营业利润66,437,352.6526,848,666.6745,517,120.7818,605,899.54加：投资收益-11,294,653.10-8,094,321.03-907,145.78-11,026,274.17补贴收入0.000.000.00营业外收入8,151,849.511,032,740.51161,991.89245,721.90减：营业外支出882,934.22875,759.350.00361,474.45四、利润总额62,411,614.8418,911,326.8044,771,966.897,463,872.82减：所得税9,131,866.342,121,815.125,779,341.331,080,000.00减：少数股东损益3,093,175.8957,878.630.000.00五、净利润50,186,572.6116,731,633.0538,992,625.566,383,872.82加：年初未分配利润-484,789,446.64283,889,764.43-475,070,886.91306,139,876.79其他转入0.000.000.00六、可供分配的利润-434,602,874.03300,621,397.48-436,078,261.35312,523,749.61减：提取法定盈余公积0.000.000.000.00提取法定公益金0.000.000.000.00七、可供股东分配的利润-434,602,874.03300,621,397.48-436,078,261.35312,523,749.61减：应付优先股股利0.000.00提取任意盈余公积0.000.00应付普通股股利0.000.000.0070,029,000.00转作股本的普通股股利0.000.00八、未分配利润-434,602,874.03300,621,397.48-436,078,261.35242,494,749.61 详见《三九医药股份有限公司2005年第一季度报告》（据“深圳证券交易所”；医药网整理，严禁转载） 医药网新闻